Seizures are a well‐recognized and often prominent manifestation of autoimmune
encephalitic syndromes. Progress in detection of pathogenic neural autoantibodies has led …

The rapid expansion in the number of encephalitis disorders associated with autoantibodies
against neuronal proteins has led to an incremental increase in use of the term “autoimmune …

Over the last decade, advances in genetics, neuroimaging and EEG have enabled the
aetiology of epilepsy to be identified earlier in the disease course than ever before. At the …

Objective To compare acute treatment responses and long-term outcome in leucine-rich
glioma-inactivated 1 (LGI1) antibody encephalitis. Methods Retrospective case series of 118 …

Objective To perform a systematic review of the current scientific literature in order to identify
variables associated with patient prognosis in autoimmune encephalitis. Methods We …

Importance Autoimmune epilepsy is an underrecognized condition, and its true incidence is
unknown. Identifying patients with an underlying autoimmune origin is critical because these …

Objective Drug‐resistant seizures are common in patients with leucine‐rich, glioma‐
inactivated 1 (LGI1)‐IgG associated and contactin‐associated protein‐like 2 (CASPR2)‐IgG …

Although seizures are frequent in all types of autoimmune encephalitis, the risk for chronic
epilepsy is dependent on the antigen: lower if located on the cell-surface, and higher if …

The field of autoimmune epilepsy has evolved substantially in the last few decades with
discovery of several neural autoantibodies and improved mechanistic understanding of …

Objective To validate predictive models for neural antibody positivity and immunotherapy
response in epilepsy. Methods We conducted a retrospective study of epilepsy cases at …